• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    More On ASTRAZEN.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    AstraZeneca Pharma India Limited (ASTRAZEN.NS)

    -NSE
    806.15 Down 6.05(0.74%) Dec 19, 4:59AM EST
    Add to Portfolio
    Prev Close:812.20
    Open:811.00
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:803.00 - 818.65
    52wk Range:725.20 - 1,286.00
    Volume:1,824
    Avg Vol (3m):10,211
    Market Cap:20.31B
    P/E (ttm):N/A
    EPS (ttm):-18.51
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback